This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Beckman Research Institute, City of Hope. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: David Colcher: Innovator in Cancer Treatment
Introduction
David Colcher is a prominent inventor based in Duarte, CA (US). He has made significant contributions to the field of cancer treatment through his innovative work on targeted therapies. His research focuses on developing advanced solutions for treating TAG72-positive tumors.
Latest Patents
David Colcher holds a patent for "TAG72 targeted chimeric antigen receptor modified T cells for treatment of TAG72-positive tumors." This patent describes chimeric antigen receptors that are specifically targeted to TAG72, which can be utilized to treat ovarian cancer and other related cancers. His work in this area represents a significant advancement in cancer therapy.
Career Highlights
Colcher is affiliated with City of Hope, a leading research and treatment center. His role at this institution allows him to collaborate with other experts in the field and contribute to groundbreaking research aimed at improving patient outcomes.
Collaborations
Some of his notable coworkers include Saul J. Priceman and John P. Murad. Their collective expertise enhances the research efforts at City of Hope, fostering an environment of innovation and discovery.
Conclusion
David Colcher's contributions to cancer treatment through his patented innovations highlight the importance of targeted therapies in modern medicine. His work continues to pave the way for advancements in the fight against cancer.